← All reportsView on Symbol
INSM

INSM

Medium conviction

Insmed Incorporated

Healthcare · NASDAQ

$21.2B mkt cap

Brief updated Jun 15, 2026

Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex

Decifer Research·AI synthesis

Insmed faces risk-off rotation

Insmed Incorporated is a biopharmaceutical company with 1596.0% year-over-year revenue growth. The company's conviction score is 38/100, indicating medium confidence. Analysts have a buy consensus rating, despite a negative P/E ratio of -17.8x. This setup is interesting due to the significant revenue growth and negative net margin of -14444.0%

Why now

The current market uncertainty, driven by US-Iran unease, makes this a critical moment to assess Insmed's risk profile. The recent 400-point drop in the Dow and small caps cratering highlights the market's risk-off rotation

Key risks

Valuation risk is a major concern, given the negative P/E ratio and DCF intrinsic value of $-191. Execution risk is also a factor, as the company's negative net margin and significant revenue growth must be sustained. Macro risk, driven by geopolitical events, may impact investor appetite for biopharmaceutical stocks

What to watch

Insmed's ability to maintain revenue growth and improve its net margin will be key indicators to watch over the next quarter. The company's upcoming financial reports and any updates on its ARIKAYCE treatment will be crucial in confirming or denying the thesis

32Medium conviction Conviction
macro
5/25
analyst
22/38
momentum
10/20
forward catalyst
0/15
valuation
15/23
highs
-12/12
news catalyst
0/12
options flow
0/12
peer network
8/8
counter thesis
0/3
Key financials
Revenue growth (YoY)1596.0%
Gross margin8156.0%
Operating margin-13774.0%
Net margin-14444.0%
P/E ratio-17.8x
Return on equity-13011.0%
FCF yield-449.0%
Debt / equity1.1x
EV / sales26.1x
Valuation
Analyst consensusBUY
DCF fair value$-191
Next EPS estimate$0.92
Macro context

Stock Market Today: Dow Drops 400 Points, Small Caps Crater On U.S.-Iran Unease; Macy's Wobbles (Live Coverage)

The Dow Jones dropped 400 points and small caps declined significantly due to rising tensions between the U.S. and Iran, sparking geopolitical uncertainty and risk-off sentiment in the markets. This escalation has the potential to impact global markets and asset classes.

Jun 3, 2026

Bitcoin, Ethereum, XRP Slide, Dogecoin Flat As US Launches 'Proportional' Strikes Against Iran: Analyst Sees BTC's Strong Rebound To $74,000 Soon

The US has launched 'proportional' strikes against Iran, leading to a slide in cryptocurrency prices, but an analyst predicts a strong rebound in Bitcoin to $74,000 soon. This escalation in geopolitical tensions could impact market volatility and asset prices.

Jun 10, 2026

S&P 500, Dow, Nasdaq Futures Decline As US Launches Fresh ‘Self-Defense Strikes’ On Iran: SMCI, TLRY, DKNG, CBRL In Focus

The US has launched fresh 'self-defense strikes' on Iran, leading to a decline in S&P 500, Dow, and Nasdaq futures, as geopolitical tensions escalate and investors become risk-averse. This escalation may lead to further market volatility and potential supply chain disruptions.

Jun 10, 2026

US-Iran Flare-Up Drags US Equity Futures Pre-Bell as Middle East Tensions Re-Escalate

The US-Iran flare-up has led to a re-escalation of Middle East tensions, causing US equity futures to decline pre-bell, indicating a potential risk-off sentiment in the markets. This escalation may lead to increased volatility and market uncertainty.

Jun 10, 2026

Analyst intelligence
33 Buy1 Hold1 Sell
Earnings intelligence

Earnings surprises

+21.1%

2026-05

-43.9%

2026-02

-31.6%

2025-10

-30.8%

2025-08

-6.0%

2025-05

Recent updates
other macro4d ago

TSMC stock drops 4.1% amid a $2 trillion AI rout, indicating a potential shift in investor sentiment towards AI-related stocks and the broader tech sector. This event may have implications for the tech industry and the global economy.

geopolitical escalation4d ago

The US equity indexes are sliding ahead of Fed Governor Warsh's press briefing and big-tech results, as President Trump vows to hit Iran hard, escalating geopolitical tensions. This escalation could lead to increased market volatility and risk aversion.

central bank rate decision4d ago

The equities market is experiencing intraday losses ahead of the highly anticipated Federal Reserve decision, which could significantly impact market direction and investor sentiment. The decision, coupled with major tech earnings reports, is poised to influence the overall economic outlook.

natural disaster5d ago

TSMC's Japan semiconductor fabrication plant is gradually resuming operations following an earthquake-induced disruption. This matters because TSMC is a critical node in the global semiconductor supply chain, and even partial outages can ripple through electronics and chip-dependent industries.

oil supply shock5d ago

US Strategic Petroleum Reserve levels have fallen to a 43-year low, reducing the government's capacity to buffer oil price shocks at a time of active Middle East conflict. This structural vulnerability in US energy policy raises concerns about energy security and the ability to respond to supply disruptions.

Generated Mon, 15 Jun 2026 05:26:42 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.